Antibody interference in thyroid assays: A potential for clinical misinformation

Clinical Chemistry

Volumn 44, Issue 3, 1998, Pages 440-454

  Després, Normand ^a   Grant, Andrew M ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; RHEUMATOID FACTOR;

GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; LIOTHYRONINE BLOOD LEVEL; PROTEIN CROSS LINKING; REVIEW; THYROID FUNCTION TEST; THYROXINE BLOOD LEVEL; TOXIC GOITER;

EID: 0031911110     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.3.440     Document Type: Review

References (118)

1. Kohse KP, Wisser H. Antibodies as a source of analytical errors. J Clin Chem Clin Biochem 1990;28:881-92.
2. Sakata S, Nakamura S, Miura K. Autoantibodies against thyroid hormones or iodothyronine [Review]. Ann Intern Med 1985;103: 579-89.
3. Boscato LM, Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem 1988;34:27-33.
4. Nahm MH, Hoffmann JW. Heteroantibody: phantom of the immunoassay [Editorial]. Clin Chem 1990;36:829.
5. Levinson SS. Antibody multispecificity in immunoassay interference. Clin Biochem 1992;25:77-87.
6. Kroll MH, Elin RJ. Interference with clinical laboratory analyses [Review]. Clin Chem 1994;40:1996-2005.
7. Dayan CM, Gilbert GH. Chronic autoimmune thyroiditis [Review]. N Engl J Med 1996;335:99-107.
8. Beever K, Bradbury J, Phillips D, McLachlan SM, Pegg C, Goral A, et al. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 1989;35:1949-54.
9. Volpé R. Autoimmune endocrinopathies: aspects of pathogenesis and the role of immune assays in investigation and management. Clin Chem 1994;40:2132-5.
10. Feldt-Rasmussen U. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor. Clin Chem 1996;42:160-3.
11. Robbins J, Rall JE, Rawson RW. An unusual instance of thyroxine binding by human serum gamma globulin. J Clin Endocrinol Metab 1956;16:573-9.
12. Calzi LL, Benvenga S, Battiato S, Santini F, Trimarchi F. Autoantibodíes to thyroxin and triiodothyronine in the immunoglobulin G fraction of serum. Clin Chem 1988;34:2561-2.
13. Desai RK, Bredenkamp B, Jialal I, Omar MAK, Rajput MC, Joubert SM. Autoantibodies to thyroxin and triiodothyronine. Clin Chem 1988;34:944-8.
14. 4: intérêt de leur dépistage [Letter]. Presse Méd 1992;21: 217.
15. Sakata S. Autoimmunity against thyroid hormones. Crit Rev Immunol 1994;14:157-91.
16. Sakata S, Matsuda M, Ogawa T, Rakuno H, Matsui I, Sarui H, Yasuda K. Prevalence of thyroid hormone autoantibodies in healthy subjects. Clin Endocrinol 1994;41:365-70.
17. Vyas SK, Wilkin TJ. Thyroid hormone autoantibodies and their implications for free thyroid hormone measurement. J Endocrinol Invest 1994;17:15-21.
18. 4) radioimmunoassay levels secondary to circulating thyroid hormone autoantibodies. Clin Endocrinol 1978;8:133-9.
19. 4) in sera containing antibodies against the hormones. Clin Biochem 1981;14:11-3.
20. Bhagat CI, Garcia-Webb P, Watson F, Beilby JP. Interference in radioimmunoassay of total serum thyroxin and free thyroxin due to thyroxin-binding autoantibodies [Letter]. Clin Chem 1983;29: 1324-5.
21. Beck-Peccoz P, Romelli PB, Cattaneo MG, Faglia G, White EL, Barlow JW, Stockigt JR. Evaluation of free thyroxine methods in the presence of iodothyronine-binding autoantibodies. J Clin Endocrinol Metab 1984;58:736-9.
22. John R, Henley R, Shankland D. Concentrations of free thyroxine and free triiodothyronine in serum of patients with thyroxine- and triiodothyronine-binding autoantibodies. Clin Chem 1990;36: 470-3.
23. Ritter D, Brown W, Nahm MH, Ladenson JH, Scott MG. Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterization and prevalence. Clin Chem 1994;40:1940-3.
24. Keffer JH. Preanalytical considerations in testing thyroid function. Clin Chem 1996;42:125-34.
25. Nelson JC, Wilcox RB. Analytical performance of free and total thyroxine assays. Clin Chem 1996;42:146-54.
26. Chaussain JL, Binet E, Job JC. Antibodies to human thyrotropin in the serum of certain hypopituitary dwarfs. Rev Eur Etudes Clin Biol 1972;17:95-9.
27. Ochi Y, Nagamune T, Nakajima Y, Ishihara M, Kajita Y, Hachiya T, Ogura H. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies. Acta Endocrinol 1989;120:773-7.
28. Akamizu T, Mori T, Imura H, Noh J, Hamada N, Ito K, et al. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders. J Endocrinol Invest 1989;12:483-8.
29. Noh J, Hamada N, Saito H, Oyanagi H, Ishikawa N, Momotani N, et al. Evidence against the importance in the disease process of antibodies to bovine thyroid stimulating hormone found in some patients with Graves' disease. J Clin Endocrinol Metab 1989;68: 107-13.
30. Yamamoto M, Fuwa Y, Chimori K, Yamakita N, Sakata S. A case of progressive systemic sclerosis (PSS) with silent thyroiditis and anti-bovine thyrotropin antibodies. Endocrinol Jpn 1991;38:265-70.
31. Ogawa T, Sakata S, Nakamura S, Taxuno H, Matsui I, Sarui H, Yasuda K. Thyroid hormone autoantibodies in patients with Graves' disease: effect of anti-thyroid drug treatment. Clin Chim Acta 1994;228:113-22.
32. Wang PW, Huang MJ, Liu RT, Chen CD. Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies. Acta Endocrinol 1990;122:22-8.
33. Allan DJ, Murphy F, Needham CA, Barron N, Wilkins TA, Midgley JEM. Sensitive test for thyroid hormone autoantibodies in serum [Letter]. Lancet 1982;ii:824.
34. John R. Antibodies to thyroid hormone analogues [Letter]. Clin Chim Acta 1992;212:153-4.
35. Sapin R, Gasser F, Chambron J. Different sensitivity to anti-triiodothyronine autoantibodies of two direct radioimmunoassays of free triiodothyronine [Tech Brief]. Clin Chem 1990;36: 2141-2.
36. Sapin R, Gasser F, Schlienger JL, Chambron J. Dosages de la triiodothyronine libre utilisant un anticorps marqué: évaluation et comparaison à un dosage avec traceur analogue. (Labeled antibody assays for measuring free triiodothyronine: evaluation and comparison with a labeled analog method.) Ann Biol Clin 1993;51:13-8.
37. Sapin R, Schlienger JL, Gasser F, Chambron J. Anti-triiodothyronine auto-antibody interference in recent free thyroid hormone assays. Clin Biochem 1996;29:89-92.
38. John R, Othman S, Parkes AB, Lazarus JH, Hall R. Interference in thyroid-function tests in postpartum thyroiditis. Clin Chem 1991; 37:1397-400.
39. Sakata S, Maekawa H, Ogawa T, Sarui H, Matsuda M, Endo J, et al. A case of Hashimoto's thyroiditis with antibodies to thyroid hormone analogues. Clin Chim Acta 1992;207:129-36.
40. Deam D, Goodwin M, Ratnaike S. Comparison of four methods for free thyroxin. Clin Chem 1991;37:569-72.
41. Crino A, Borrelli P, Salvatori R, Cortelazzi D, Roncoroni R, Beck-Peccoz P. Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones. J Endocrinol Invest 1992;15:113-20.
42. Sapin R, Gasser F, Boehn A, Rondeau M. Spuriously high concentration of serum free thyroxine due to anti-triiodothyronine antibodies [Tech Brief]. Clin Chem 1995;41:117-8.
43. 4 assay. J Clin Pathol 1994; 47:181-2.
44. Tokmakjian SD, Haines DSM, Edmonds MW. Interference in assay of free triiodothyronine by triiodothyronine-binding antibodies [Letter]. Clin Chem 1991;37:2150.
45. Heyma P, Harrison LC. Autoantibodies to thyroid hormones: association with falsely low hormone levels measured by 'Amerlex' assay. Clin Chim Acta 1986;161:239-42.
46. Iitaka MI, Fukasawa N, Hara Y, Yanagisawa M, Hase K, Miura S, et al. The mechanism for the discrepancy between serum total and free thyroxine values induced by autoantibodies: report on two patients with Graves' disease. Acta Endocrinol 1990;123: 123-8.
47. Sapin R, Gasser F. Anti-solid phase antibodies interfering in labeled-antibody assays of free thyroid hormones [Letter]. Clin Chem 1995;41:1790-1.
48. Sapin R, Gasser F, Schlienger JL. Familial dysalbuminemic hyperthyroxinemia and thyroid hormone autoantibodies: interference in current free thyroid hormone assays. Horm Res 1996; 45:139-41.
49. Momotani N, Ito K, Ohnishi H, Katsuki T, Yamamoto M. Deceptively high thyroid hormone levels in a neonate due to autoantibodies against thyroid hormones transferred from a mother with Graves' disease. J Endocrinol Invest 1992;15:201-4.
50. Sarui H, Nagai K, Kametani M, Ogawa T, Tokimitsu N, Sakata S. Autoimmune hepatitis and hypothyroidism associated with antithyroid hormone autoantibodies. Intern Med 1993;32:21-5.
51. Fielding AM. Prevalence of serum autoantibody binding of Amerlex thyroxin analog. Clin Chem 1984;30:501-2.
52. 3) analysis on the immuno 1 analyzer. Clin Biochem 1995;28:55-62.
53. Lazarus JH, John R, Ginsberg J, Hughes IA, Shewring G, Smith BR, et al. Transient neonatal hyperthyrotropinemia: a serum abnormality due to transplacentally acquired antibody to thyroid stimulating hormone. Br Med J 1983;286:592-4.
54. Stubbs PJ, Oppert SA, Collinson PO. A cautionary tale: inappropriate drug treatment after false-positive diagnosis of thyrotoxicosis. Clin Chem 1990;36:1381-3.
55. Sugenoya A, Mizuno E, Haniuda M, Fujimori M, Masuda H, Kasuga Y, et al. Anti-triiodothyronine autoantibodies in a euthyroid woman: confirmation of immunoglobulin G antibodies employing Protein A column chromatography. Acta Endocrinol 1991; 124:115-20.
56. 4 [Letter]. Presse Med 1992;21:676.
57. 3. J Clin Endocrinol Metab 1983;57:851-4.
58. Levine S, Noth R, Loo A, Chopra IJ, Klee GG. Anomalous serum thyroxin measurement with the Abbott TDx procedure. Clin Chem 1990;36:1838-40.
59. Mae N, Liberato DJ, Chizzonite R, Satoh H. Identification of high-affinity anti-IL-1 alpha autoantibodies in normal human serum as an interfering substance in a sensitive enzyme-linked immunosorbent assay for IL-1 alpha. Lymphokine Cytokine Res 1991;10:61-8.
60. Martins TB, Jaskowski TD, Mouritsen CL, Hill HR. An evaluation of the effectiveness of three immunoglobulin G (IgG) removal procedures for routine IgM serological testing. Clin Diagn Lab Immunol 1995;2:98-103.
61. 4) autoantibodies. Endocrinol Jpn 1992;39:245-50.
62. Sakata S, Komaki T, Ogawa T, Takuno H, Matsui I, Sarui H, et al. Evaluation of thyroid function in patients with thyroid hormone autoantibodies. Clin Chim Acta 1993;219:23-34.
63. Nakamura S, Sakata S, Komaki T, Kamikubo K, Yasuda K, Miura K. An improved and simplified method for the detection of thyroid hormone autoantibodies (THAA) in serum. Endocrinol Jpn 1986; 33:415-22.
64. Hunter WM, Budd PS. Circulating antibodies to ovine and bovine immunoglobulin in healthy subjects: a hazard for immunoassays [Letter]. Lancet 1980;ii:1136.
65. Prince AM, Brotman B, Jass D, Ikram H. Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet 1973;i:1346-50.
66. Kricka LJ, Schmerfeld-Pruss D, Senior M, Goodman DBP, Kaladas P. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem 1990;36:892-4.
67. Howanitz PJ, Lamberson HV, Howanitz JH, Ennis KM. Circulating human antibodies as a cause of falsely depressed ferritin values. Clin Biochem 1983;16:341-3.
68. Vladutiu AO, Sulewiski JM, Pudlak KA, Stull CG. Heterophilic antibodies interfering with radioimmunoassay: a false positive pregnancy test. JAMA 1982;19:2489-90.
69. Thompson RJ, Jackson AP, Langlois N. Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects - incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme. Clin Chem 1986;32:476-81.
70. Sosolik RC, Hitchcock CL, Becker WJ. Heterophilic antibodies produce spuriously elevated concentrations of the MB isoenzyme of creatine kinase in a selected patient population. Am J Clin Pathol 1997;107:506-10.
71. Primus FJ, Kelly EA, Hanse HJ, Goldenberg DM. Sandwich-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem 1988;34:261-4.
72. Hertel A, Baum R. Influence of human anti-murine antibodies on in vitro assays in ovarian cancer patients. Hybridoma 1993;12: 571-6.
73. Boscato LM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986;32:1491-5.
74. Laurberg P. Persistent problems with the specificity of immunometric TSH assays. Thyroid 1993;3:279-83.
75. Fiad TM, Duffy J, McKenna TJ. Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies. Clin Endocrinol 1994;41:391-5.
76. Dillman RO, Shawler DL, McCallister TJ, Halpern SE. Human anti-mouse antibody response in cancer patients following single low-dose injections of radiolabeled murine monoclonal antibodies. Cancer Biother 1994;9:17-28.
77. 131I-murine monoclonal antibody for radioimmunolocalisation. Br J Cancer 1986;53: 289-92.
78. Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC Jr. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 1985;45:879-85.
79. Courtenay-Luck NS, Epenetos AA, Moore R, Larche M, Pectasides D, Dhokia B, Ritter MA. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res 1986;46:6489-93.
80. Legouffe E, Liautard J, Gaillard JP, Rossi JF, Wijdenes J, Bataille R, et al. Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6. Clin Exp Immunol 1994;98:323-9.
81. Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC Jr. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 1985;45:879-85.
82. Howanitz PJ, Howanitz JH, Lamberson HV, Ennis KM. Incidence and mechanism if spurious increases in serum thyrotropin. Clin Chem 1982;28:427-31.
83. Gendrel D, Feinstein MC, Grenier J, Roger M, Ingrand J, Chaussain JL, et al. Falsely elevated serum thyrotropin (TSH) in newborn infants: transfer from mothers to infants of a factor interfering in the TSH radioimmunoassay. J Clin Endocrinol Metab 1981;52:62-5.
84. Schaison G, Thomopoulos P, Moulias R, Feinstein MC. False hyperthyrotropinemia induced by heterophilic antibodies against rabbit serum. J Clin Endocrinol Metab 1981;53:200-2.
85. 2 conjugate and polyclonal mouse IgG. Clin Chem 1992;38:1737-42.
86. Price T, Beatty BG, Beatty JD, McNally AJ. Human anti-murine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay. Clin Chem 1991;37:51-7.
87. Cusick CF, Mistry K, Addison GM. Interference in a two-site immunoradiometric assay for thyrotropin in a child [Letter]. Clin Chem 1985;31:348-9.
88. Baum RP, Niesen A, Hertel A, Nancy A, Hess H, Donnerstag B, et al. Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma. Cancer 1994;73:1121-5.
89. 2 fragments in ovarian cancer patients. Nucl Med Com 1995;16:853-9.
90. 2 monoclonal antibody to patients with ovarian cancer. J Nucl Med 1992;33:1958-63.
91. Watts MJ, Wisdom NM, Tyrrell DA, Hale G, Connor SE. Low immunogenicity of therapeutic rat CD45 antibodies when used for pre-treatment of donor organs for transplantation. Ther Immunol 1995;2:23-9.
92. Iitaka M, Kitahama S, Fukasawa N, Miura S, Kawakami Y, Sakurai S, et al. Incidence of anti-mouse IgG in normal subjects and patients with autoimmune thyroid disease. Intern Med 1992;31:984-8.
93. Hamilton RG. Rheumatoid factor interference in immunological methods. Monogr Allergy 1989;26:27-44.
94. Zweig MH, Csako G, Benson CC, Weintraub BD, Kahn BB. Interference by anti-immunoglobulin G antibodies in immunoradiometric assays for thyrotropin involving mouse monoclonal antibodies. Clin Chem 1987;33:840-4.
95. Brennan MD, Klee GG, Preissner CM, Hay ID. Heterophilic serum antibodies: a cause for falsely elevated serum thyrotropin levels. Mayo Clin Proc 1987;62:894-8.
96. Finlayson J, Sneddon W, Percy-Robb IW. Interference in commercial assays for thyrotropin [Letter]. Lancet 1987;i:445-6.
97. John R, Henley R. Interference in commercial assays for thyrotropin [Letter]. Lancet 1987:i:446.
98. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;42:140-5.
99. Hedenborg G, Pettersson T, Carlström A. Heterophilic antibodies causing falsely raised thyroid-stimulating-hormone results [Letter]. Lancet 1979;i:755.
100. Howanitz PJ, Howanitz JH, Lamberson HV, Benedict S. Spurious TSH (thyroid stimulating hormone) elevation: a case report [Abstract]. Clin Chem 1980;26:1020.
101. Harvey RD, McHardy KC, Trainer PJ, Reid I. Interference in modified immunoradiometric assay for thyrotropin [Letter]. Lancet 1988;1:716.
102. Skovsted L, Mølholm Hansen J. Falsely raised serum thyrotropin with modified immunoradiometric assay [Letter]. Lancet 1988: i:359.
103. Czernichow P, Vandalem JL, Hennen G. Transient neonatal hyperthyrotropinemia: a factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mothers. J Clin Endocrinol Metab 1981;53:387-93.
104. Zweig MH, Csako G, Spero M. Escape form blockade of interfering heterophile antibodies in a two-site immunoradiometric assay for thyrotropin. Clin Chem 1988;34:2589-91.
105. Turpeinen U, Lehtovirta P, Stenman UH. CA 125 determined by three methods in samples from patients with human anti-mouse antibodies (HAMA). Clin Chem 1995;41:1667-9.
106. Iitaka M, Ishii J, Ito K. Spurious serum thyrotropin values caused by IgM class antibody to mouse IgG [Letter]. Clin Chem 1992; 38:311-2.
107. McCarthy RC, Ryan FJ, McKenzie CM. Interference in immunoenzymometric assays caused by IgM anti-mouse IgG antibodies. Arch Pathol Lab Med 1988;112:901-7.
108. Kuroki M, Matsumoto Y, Arakawa F, Haruno M, Murakami M, Kuwahara M, et al. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. J Immunol Methods 1995;180:81-91.
109. Kahn BB, Weintraub BD, Csako G, Zweig MH. Factitious elevation of thyrotropin assay: implications for the use of monoclonal antibodies in "sandwich" immunoassay. J Clin Endocrinol Metab 1988;66:526-33.
110. Wood JM, Gordon DL, Rudinger AN, Brooks MM. Artifactual elevation of thyroid-stimulating hormone. Am J Med 1991;90: 261-2.
111. Boerman OC, Gegers MFG, Poels LG, Kenemans P, Thomas CMG. Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay. Clin Chem 1990;36:888-91.
112. Iitaka M, Ishii J, Ishikawa N, Yoshimura H, Momotani N, Saitou H, Ito K. A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis. Endocrinol Jpn 1991;38: 667-71.
113. Reinsberg J. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. Clin Biochem 1996;29:145-8.
114. Klatt KK, Klee GG. Significance of human anti-mouse antibodies (HAMA) in immunoassays [Abstract]. Clin Chem 1997;43:S137.
115. Hamilton RG, Whittington K, Warner NB, Arnett FC. Human IgM rheumatoid factor reactivity with rabbit, sheep, goat and mouse immunoglobulin [Abstract]. Clin Chem 1988;34:1165.
116. Carson DA. Rheumatoid factor. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1993:155-63.
117. Courtenay-Luck NS, Epenetos AA, Winearls CG, Ritter MA. Pre-existing human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res 1987;47:4520-5.
118. Norden AGW, Jackson RA, Norden LE, Griffin AJ, Barnes MA, Little JA. Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clin Chem 1997;43:957-62.